|
ESD expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.858830E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.648100E-04 |
| Normal-vs-Stage2 |
5.589400E-01 |
| Normal-vs-Stage3 |
5.745200E-01 |
| Normal-vs-Stage4 |
4.733000E-01 |
| Stage1-vs-Stage2 |
2.485800E-01 |
| Stage1-vs-Stage3 |
2.129800E-01 |
| Stage1-vs-Stage4 |
1.326420E-01 |
| Stage2-vs-Stage3 |
9.917200E-01 |
| Stage2-vs-Stage4 |
2.849400E-01 |
| Stage3-vs-Stage4 |
3.101400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.979300E-03 |
| Normal-vs-AfricanAmerican |
2.425400E-01 |
| Normal-vs-Asian |
2.291800E-01 |
| Caucasian-vs-AfricanAmerican |
3.447000E-01 |
| Caucasian-vs-Asian |
5.232800E-01 |
| AfricanAmerican-vs-Asian |
3.787600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.034600E-04 |
| Normal-vs-Female |
3.847600E-01 |
| Male-vs-Female |
5.079700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.536400E-01 |
| Normal-vs-Extreme_Weight |
7.420300E-04 |
| Normal-vs-Obese |
1.177550E-01 |
| Normal-vs-Extreme_Obese |
2.878000E-01 |
| Normal_Weight-vs-Extreme_Weight |
1.081950E-01 |
| Normal_Weight-vs-Obese |
5.221200E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.796600E-01 |
| Extreme_Weight-vs-Obese |
2.897400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.863800E-01 |
| Obese-vs-Extreme_Obese |
7.094600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.917800E-03 |
| Normal-vs-Age(41-60Yrs) |
2.869400E-01 |
| Normal-vs-Age(61-80Yrs) |
1.417950E-04 |
| Normal-vs-Age(81-100Yrs) |
5.391000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.809690E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.208000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.515800E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.468080E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.605600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.731600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
9.92210000000382E-05 |
| Normal-VS-Type2 PRCC |
9.120600E-01 |
| Normal-VS-KIRP CIMP |
1.47859999999334E-06 |
| Normal-VS-Unclassified PRCC |
1.018580E-01 |
| Type1 PRCC-VS-Type2 PRCC |
6.796200E-03 |
| Type1 PRCC-VS-KIRP CIMP |
6.086500E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
2.929400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.562600E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
1.648640E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.382090E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.236400E-02 |
| Normal-vs-N1 |
8.360600E-01 |
| Normal-vs-N2 |
2.337100E-03 |
| N0-vs-N1 |
2.912200E-01 |
| N0-vs-N2 |
3.030200E-01 |
| N1-vs-N2 |
2.565600E-01 |
|
|
